Mainz Biomed Reports Positive Topline Results from Pooled Study Evaluating Novel mRNA Biomarkers and Proprietary AI Algorithm for Integration into Pivotal FDA PMA Clinical Trial for Next Generation Colorectal Cancer Diagnostic

Groundbreaking topline results demonstrated sensitivity for colorectal cancer of 92% with specificity of 90% and best-in-class sensitivity for advanced adenoma of 82%690 subjects analyzed including...

Related Keywords

Berkeley ,California ,United States ,Germany ,Guido Baechler ,Mainz Biomed Colofuture Europe ,Mainz Biomed ,Hershel Berry ,Anne Hennecke Caroline Bergmann ,Centers For Disease ,Blueprint Life Science Group ,Us Preventive Services Task ,Exchange Commission ,Facebook ,World Cancer Research Fund International ,Mc Services ,Linkedin ,Company Colofuture ,Chief Executive Officer ,Disease Control ,Previously Twitter ,World Cancer Research Fund ,Services Task Force ,Polymerase Chain Reaction Based ,Private Securities Litigation Reform Act ,